Closing Perspectives: Individualized Care and the Path Beyond Steroids

In this closing segment, faculty distill the practical philosophy that runs through the program: a center-based start with a deliberate, clearly communicated transition remains the right approach for most patients. The panel identifies who should stay longer under transplant-center care, including patients not tolerating therapy, those whose disease is not yet responding, and those where compliance or resource needs warrant closer support. Faculty reiterate that transitioning care is about sharing management with clear expectations, not handing it off, so patients and families are never left to navigate alone. The discussion then looks ahead with optimism, envisioning more individualized treatment, better biomarkers to match the right therapy to the right patient, smarter sequencing and combination of the available agents, and the eventual goal of reducing reliance on upfront steroids. The segment closes on how far the field has advanced and the momentum carrying chronic GVHD care forward.